Jonathan Aschoff
Stock Analyst at Roth MKM
(0.03)
# 4,835
Out of 5,099 analysts
442
Total ratings
27.2%
Success rate
-23.9%
Average return
Main Sectors:
Stocks Rated by Jonathan Aschoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTHS Pelthos Therapeutics | Maintained: Buy | $55 | $10.78 | +410.20% | 6 | Nov 4, 2026 | |
| NTHI NeOnc Technologies Holdings | Initiated Coverage: Buy | $20 | $3.07 | +551.47% | 1 | Sep 24, 2026 | |
| MDCX Medicus Pharma | Reiterated: Buy | $450 | $2.03 | +22,067.49% | 5 | Sep 9, 2026 | |
| APVO Aptevo Therapeutics | Reiterated: Buy | $21 | $1.36 | +1,444.12% | 12 | Sep 3, 2026 | |
| CELZ Creative Medical Technology Holdings | Reiterated: Buy | $20 | $0.6735 | +2,869.56% | 9 | Aug 20, 2026 | |
| CLNN Clene | Reiterated: Buy | $30 | $3.77 | +695.76% | 7 | Aug 17, 2026 | |
| GTBP GT Biopharma | Reiterated: Buy | $3 | $5.27 | -43.07% | 6 | Aug 17, 2026 | |
| TENX Tenax Therapeutics | Reiterated: Buy | $30 → $5 | $1.84 | +171.74% | 8 | Aug 10, 2026 | |
| REVB Revelation Biosciences | Reiterated: Buy | $16 | $4.43 | +261.17% | 14 | Aug 7, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $21 | $10.26 | +104.68% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $620 | $8.30 | +7,369.88% | 17 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $33 | $19.34 | +70.63% | 3 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.1641 | +5,993.85% | 15 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.8899 | +911.35% | 12 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $14 → $11 | $1.31 | +739.69% | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $15 | $1.48 | +913.51% | 10 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $0.000001 | n/a | 8 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $2 | $0.0005 | n/a | 11 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $11 | $5.91 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 | €2.39 | n/a | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.872 | n/a | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.60 | $0.03 | n/a | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 | $4.83 | n/a | 9 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $36 | $33.41 | n/a | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 → $24 | $2.06 | n/a | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $620 → $500 | $0.0111 | n/a | 3 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $7.71 | n/a | 2 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.7452 | n/a | 1 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $30 | $0.1831 | n/a | 3 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.095 | n/a | 5 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $8 | $0.000001 | n/a | 5 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.000001 | n/a | 4 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $8.47 | n/a | 1 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $0.0002 | n/a | 3 | Nov 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $1.66 | n/a | 17 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $11 | $3.05 | n/a | 3 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $26 | $1.32 | n/a | 2 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.39 | n/a | 1 | Apr 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.0111 | n/a | 8 | Sep 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.23 | n/a | 12 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $0.2847 | n/a | 17 | Sep 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $139.61 | n/a | 5 | Aug 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $4.54 | n/a | 10 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $92 | $117.59 | n/a | 14 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $0.7258 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $29.71 | n/a | 11 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3 | $8.09 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $3.94 | n/a | 6 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $60.75 | n/a | 21 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $36.39 | n/a | 16 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $37.76 | n/a | 13 | Aug 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $489 | $973.36 | n/a | 18 | Mar 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.3561 | n/a | 4 | Nov 12, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $1.04 | n/a | 3 | Dec 8, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $55.66 | n/a | 3 | Oct 24, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $601.32 | n/a | 1 | Feb 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $0.90 | n/a | 1 | Jan 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.92 | n/a | 2 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $11 | $128.62 | n/a | 2 | Apr 16, 2012 |
Pelthos Therapeutics
Nov 4, 2026
Maintained: Buy
Price Target: $55
Current: $10.78
Upside: +410.20%
NeOnc Technologies Holdings
Sep 24, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $3.07
Upside: +551.47%
Medicus Pharma
Sep 9, 2026
Reiterated: Buy
Price Target: $450
Current: $2.03
Upside: +22,067.49%
Aptevo Therapeutics
Sep 3, 2026
Reiterated: Buy
Price Target: $21
Current: $1.36
Upside: +1,444.12%
Creative Medical Technology Holdings
Aug 20, 2026
Reiterated: Buy
Price Target: $20
Current: $0.6735
Upside: +2,869.56%
Clene
Aug 17, 2026
Reiterated: Buy
Price Target: $30
Current: $3.77
Upside: +695.76%
GT Biopharma
Aug 17, 2026
Reiterated: Buy
Price Target: $3
Current: $5.27
Upside: -43.07%
Tenax Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $30 → $5
Current: $1.84
Upside: +171.74%
Revelation Biosciences
Aug 7, 2026
Reiterated: Buy
Price Target: $16
Current: $4.43
Upside: +261.17%
Zevra Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $21
Current: $10.26
Upside: +104.68%
Aug 4, 2026
Reiterated: Buy
Price Target: $620
Current: $8.30
Upside: +7,369.88%
Jul 6, 2026
Rated: Buy
Price Target: $20 → $33
Current: $19.34
Upside: +70.63%
May 26, 2026
Reiterated: Buy
Price Target: $10
Current: $0.1641
Upside: +5,993.85%
May 15, 2026
Reiterated: Buy
Price Target: $9
Current: $0.8899
Upside: +911.35%
May 5, 2026
Rated: Buy
Price Target: $14 → $11
Current: $1.31
Upside: +739.69%
Apr 2, 2026
Reiterated: Buy
Price Target: $18 → $15
Current: $1.48
Upside: +913.51%
Jul 8, 2025
Reiterated: Buy
Price Target: $4 → $3
Current: $0.000001
Upside: n/a
Jun 4, 2025
Reiterated: Buy
Price Target: $9 → $2
Current: $0.0005
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $13 → $11
Current: $5.91
Upside: n/a
May 12, 2025
Reiterated: Buy
Price Target: €12.00
Current: €2.39
Upside: n/a
Oct 23, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.872
Upside: n/a
Sep 3, 2024
Reiterated: Buy
Price Target: $0.60
Current: $0.03
Upside: n/a
May 21, 2024
Rated: Buy
Price Target: $36
Current: $4.83
Upside: n/a
Mar 7, 2024
Reiterated: Buy
Price Target: $25 → $36
Current: $33.41
Upside: n/a
Mar 5, 2024
Reiterated: Buy
Price Target: $250 → $24
Current: $2.06
Upside: n/a
Dec 18, 2023
Reiterated: Buy
Price Target: $620 → $500
Current: $0.0111
Upside: n/a
Feb 27, 2023
Reiterated: Buy
Price Target: $14
Current: $7.71
Upside: n/a
Jun 15, 2022
Initiated Coverage: Buy
Price Target: $8
Current: $0.7452
Upside: n/a
Apr 28, 2022
Reiterated: Buy
Price Target: $4 → $30
Current: $0.1831
Upside: n/a
Oct 25, 2021
Reiterated: Buy
Price Target: $24
Current: $0.095
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $2.5 → $8
Current: $0.000001
Upside: n/a
Aug 30, 2021
Reiterated: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Mar 11, 2021
Initiated Coverage: Buy
Price Target: $38
Current: $8.47
Upside: n/a
Nov 22, 2020
Reiterated: Buy
Price Target: $18
Current: $0.0002
Upside: n/a
Nov 17, 2020
Downgraded: Sell
Price Target: $8
Current: $1.66
Upside: n/a
Oct 14, 2020
Reiterated: Buy
Price Target: $14 → $11
Current: $3.05
Upside: n/a
Jul 14, 2020
Reiterated: Buy
Price Target: $13 → $26
Current: $1.32
Upside: n/a
Apr 20, 2020
Reiterated: Buy
Price Target: $9
Current: $0.39
Upside: n/a
Sep 15, 2016
Reiterated: Buy
Price Target: $14
Current: $0.0111
Upside: n/a
Sep 13, 2016
Reiterated: Buy
Price Target: $4
Current: $1.23
Upside: n/a
Sep 9, 2016
Reiterated: Buy
Price Target: $55
Current: $0.2847
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $29
Current: $139.61
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $24
Current: $4.54
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $92
Current: $117.59
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $26
Current: $0.7258
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $24 → $16
Current: $29.71
Upside: n/a
Aug 9, 2016
Reiterated: Sell
Price Target: $4 → $3
Current: $8.09
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $16
Current: $3.94
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $28
Current: $60.75
Upside: n/a
Aug 5, 2016
Reiterated: Hold
Price Target: n/a
Current: $36.39
Upside: n/a
Aug 4, 2016
Reiterated: Buy
Price Target: $16 → $18
Current: $37.76
Upside: n/a
Mar 8, 2016
Initiated Coverage: Buy
Price Target: $489
Current: $973.36
Upside: n/a
Nov 12, 2015
Reiterated: Buy
Price Target: $5
Current: $0.3561
Upside: n/a
Dec 8, 2014
Reiterated: Buy
Price Target: $16
Current: $1.04
Upside: n/a
Oct 24, 2014
Reiterated: Hold
Price Target: n/a
Current: $55.66
Upside: n/a
Feb 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $601.32
Upside: n/a
Jan 17, 2013
Downgraded: Sell
Price Target: $1
Current: $0.90
Upside: n/a
Jun 29, 2012
Reiterated: Buy
Price Target: n/a
Current: $19.92
Upside: n/a
Apr 16, 2012
Reiterated: Buy
Price Target: $13 → $11
Current: $128.62
Upside: n/a